AIX-EN-PROVENCE, France--(BUSINESS WIRE)--SuperSonic Imagine, the innovative ultrasound imaging company, is pleased to announce Kurt Kelln, 50 years-old, has been named as Executive Vice President of Sales and Marketing and Chief Business Officer. Mr. Kelln will be responsible for advancing all of SuperSonic Imagine’s key strategic and commercial partnerships as well as driving the company’s global sales growth.
Kurt Kelln has lived and worked in the USA, Germany and the UK and has an extensive knowledge of the International Healthcare Markets. In addition, Mr. Kelln possesses a wealth of experience in the field of ultrasound imaging, a domain he has worked in for more than 25 years.
Prior to joining SuperSonic Imagine in April 2012, Mr. Kelln served as Vice President of Ultrasound and Women’s Healthcare at Philips Healthcare where he implemented successful sales and marketing strategies for mature and growth markets. He was responsible for leading one of the largest and most successful sales and marketing teams in the industry.
Before Philips, Mr. Kelln spent 11 years with ATL Ultrasound in various strategic leadership positions in Operations, Administration, Sales and Marketing. He has vast experience in business strategy, sales and marketing leadership, and general management.
Mr. Kelln commented, “I am very pleased to join the dynamic and innovative team at SuperSonic Imagine. The Aixplorer® MultiWave™ Ultrasound system has a revolutionary software based platform that renders, not only outstanding image quality, but also innovative technology such as ShearWave™ Elastography and UltraFast™ Doppler. This unique platform gives impressive perspectives for future developments.” He added, “I am looking forward to maximizing the commercial potential of the Aixplorer and its technologies.”
SuperSonic Imagine Founder and CEO, Dr. Jacques Souquet (PhD.) remarked, “Kurt Kelln has a very impressive track record in business development and has been responsible for major distributor partnerships around the world. His experience, knowledge and success will be an asset for SuperSonic Imagine as we move ahead to conquer market share in the ultrasound industry.”
About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is an innovative, international company specializing in ultrasound medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with a unique ultrasound imaging technology, called MultiWave™ Technology. This technology allows Aixplorer® to be the only ultrasound system that images two types of waves to better characterize tissue; an ultrasound wave to ensure impeccable image quality and a shear wave, ShearWave™ Elastography, to compute and display true tissue stiffness in real time by acquiring images nearly 200 times faster than conventional systems.
ShearWave™ Elastography and UltraFast™ Doppler made possible by Aixplorer’s technology, allow physicians to visualise and analyse in real-time, thanks to a reliable, reproducible and extremely rapid process, the stiffness and vascularisation of tissue in order to significantly improve the detection and characterization of numerous pathologies. The company has developed many clinical applications, including for the breast, thyroid, liver and prostate. In 2009, SuperSonic Imagine was granted 510(k) clearance by the Food and Drug Administration in the United States and CE mark in Europe for the marketing of Aixplorer®. SuperSonic Imagine has an installed base of 383 Aixplorers in over 50 countries as of March 31, 2012.
Distribution agreements have been signed with prestigious companies such as Hologic (Nasdaq:HOLX) for the breast market in the U.S.A. and Canon (NYSE:CAJ) for Japan.
SuperSonic Imagine holds the exclusive right, title and interest to 28 international patents and submissions in diagnostic imaging and therapy applications.
For more information about SuperSonic Imagine, please go to www.supersonicimagine.fr